open-burger-menu
Search Icon
Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research
📈 NEW Report: Abortions, Tax Funding UP at Planned Parenthood >>
Search Icon
Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

close-panel
Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Research Type:

Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research

Sort 1464 results by:

Filter results further
Filter Applied. Clear All

Latest Posts

October 6, 2026 A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review October 6, 2026 Inside The Government Decision That Opened Up Abortion Pill Floodgates Inside The Government Decision That Opened Up Abortion Pill Floodgates October 6, 2026 Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone
Research Type
Publication Type
By State
See All
By Author
See All
Reset All Filters

Did You Know ?

Did You Know ?

In the fourth week, the embryonic heart starts beating. The neural tube, which becomes the brain and spinal cord, forms. At this point, a woman has likely only been aware of her pregnancy for one week.

Did You Know ?

In the seventh week after conception, networks of neurons produce brain waves that have been recorded as early as 6 ½ weeks after conception. The embryo spontaneously moves his arms, hands, and legs, and may even hiccup. The embryo’s heart now has all four chambers.

Did You Know ?

By the seventeenth and eighteenth week after gestation, the fetus shows a clear response to pain in multiple studies, and at least one brain pathway is mature enough to create a perception of pain. The fetus also practices breathing, crying, and breastfeeding in the womb. The fetal heart has beat over 20 million times and circulates about 55 quarts of blood per day.

Did You Know ?

In the eighth month of pregnancy the fetal brain is ready to learn! At 32 weeks after conception, neurons are creating 40,000 new connections, called synapses, every second! With repeated exposures, the fetus can learn flavors, nursery rhymes, songs, and even words that she will recognize after birth!

A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review
Latest Research / Life & the Law

A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review

This paper critically analyzes the FDA's 2021 REMS Review leading to the removal of the in-person dispensing requirement for mifepristone.

Zachary Sluzala,… Ingrid Skop,…
October 6, 2026
Inside The Government Decision That Opened Up Abortion Pill Floodgates
Latest Research / Abortion Drugs

Inside The Government Decision That Opened Up Abortion Pill Floodgates

The decision "fell well short" of the FDA's standards.

charlotte-lozier-institute Charlotte Lozier Institute
October 6, 2026
Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone
Latest Research / Life & the Law

Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone

This paper critically analyzes the FDA's 2021 literature review that served as the basis for its controversial decision to remove…

Ingrid Skop,…
October 6, 2026
Peer-Reviewed Article: FDA Lacked Evidence to Drop In-Person Abortion Drug Requirement
Latest Research / Abortion Drugs

Peer-Reviewed Article: FDA Lacked Evidence to Drop In-Person Abortion Drug Requirement

A new peer-reviewed article on the Food and Drug Administration’s (FDA) 2021 complete review of mifepristone’s Risk Evaluation and Mitigation…

charlotte-lozier-institute Charlotte Lozier Institute
October 6, 2026
Abortion Reporting: Kentucky (2025)
Latest Research / Maternal & Public Health

Abortion Reporting: Kentucky (2025)

In 2025, five brick-and-mortar abortions were reported in Kentucky by the state’s Cabinet for Health and Family Services. The data…

Elyse Gaitan Mia Steupert,…
October 5, 2026
United Kingdom Data Deficiencies Influencing U.S. FDA Decisions
Life & the Law

United Kingdom Data Deficiencies Influencing U.S. FDA Decisions

CLI's VP of Medical Affairs Ingrid Skop, together with Calum Miller, MD, and Kevin Duffy, MPH, recently published an article in Issues in Law & Medicine arguing that decisions by the FDA to pull back regulations on the abortion drug mifepristone in part relied on "flawed studies with significantly undercounted complications" from the U.K.

Ingrid Skop, M.D.,…
May 23, 2024
Life & the Law

Misleading Statements About “Life of the Mother” Exceptions in Pro-life Laws Require Correction

Recently CLI scholars Ingrid Skop, M.D. and Mary Harned, J.D. published a rebuttal in Issues in Law & Medicine to a series of misleading statements made in an article that appeared in the journal Obstetrics & Gynecology.

Ingrid Skop, M.D.,… Mary E. Harned,…
May 23, 2024
New Study Reveals FDA Relied on Cherrypicked Data to Approve Dangerous Mail-Order Abortion Drugs
Abortion Drugs

New Study Reveals FDA Relied on Cherrypicked Data to Approve Dangerous Mail-Order Abortion Drugs

A new peer-reviewed article highlights major flaws in the data used by the U.S. Food and Drug Administration (FDA) to remove medical safeguards and in-person administering of abortion drugs. These flaws illustrate the ongoing problem of lack of quality abortion reporting data in the U.S. as well as in the United Kingdom.

charlotte-lozier-institute Charlotte Lozier Institute
May 13, 2024
Maternal & Public Health

Abortion Reporting: Oklahoma (2023)

Oklahoma reported zero abortions in 2023 as of May 8th, 2024. 

charlotte-lozier-institute Charlotte Lozier Institute
May 9, 2024
Life & the Law

Gestational Limits on Abortion in the United States Compared to International Norms (April 2024)

This report compares gestational limits on abortion in the U.S. with limits in other countries and serves as an update to CLI's original 2014 study. Of 193 U.N. countries, the U.S. is one of eight countries that allows, at the federal level, abortion on demand without any gestational limits. The U.S. is also one of only 15 countries in the U.N. that permit abortion on demand past 15 weeks of gestation, meaning its abortion law is far more permissive than the vast majority of the world.

Mary E. Harned,… Mia Steupert, M.A.
April 30, 2024
Maternal & Public Health

Fact Check: “Abortion is 14 Times Safer than Childbirth”

The false claim that abortion is 14 times safer than childbirth arose from a 2012 journal article by two vocal abortion advocates, Elizabeth Raymond and David Grimes. Despite being debunked in the dozen years since, it continues to be repeated by pro-abortion media advocates. This issue of On Women's Health explains numerous reasons this statement is false and not data-driven.

Ingrid Skop, M.D.,…
April 25, 2024
Life & the Law

A Fact-Free Campaign Against Parents and Unborn Children in Alabama

Recently, Alabama passed a new law that grants immunity from both civil and criminal liability to IVF clinics for destroying human embryos, without parents’ consent and for any reason. This came in the wake of the Alabama supreme court ruling that parents can file suit when, without their consent and against their interests, a medical facility causes the death one or more of their frozen embryos. In this On Point, Richard Doerflinger clarifies the facts of the case and Alabama law, as well as countering misinformation.

Richard Doerflinger, M.A.
April 22, 2024
Maternal & Public Health

Fact Sheet: Planned Parenthood’s 2022-23 Annual Report

In April 2024, Planned Parenthood released its annual report for 2022-2023. In this fact sheet, data from that report is summarized.

charlotte-lozier-institute Charlotte Lozier Institute
April 17, 2024

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image